Total Funding
6
25
Total FundingVenture - Series Unknown raised
Growth Score
-16 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
722605
Cortria a pharmaceutical company, develops medicines for the treatment of cardiovascular diseases.
- Daniel Grau: CEO
About the Company
Cortria Corporation, a pharmaceutical company, develops medicines for the treatment of cardiovascular diseases. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in 2005 and is based in Boston, Massachusetts. As of August 24, 2010,
Cortria Corporation operates as a subsidiary of DERMENA North America Inc.
